Artificial Pancreas Device Systems Market Size, Share & Trends Analysis Report By Device Type (Threshold Suspend Device Systems, Control-to-Range Systems), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Artificial Pancreas Device Systems Market Growth & Trends
The global artificial pancreas device systems market size is anticipated to reach USD 980.95 million by 2030, expanding at a CAGR of 18.94% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increasing geriatric population, growing incidence of diabetes, and the rising prevalence of obesity are the major factors driving the market growth. In addition, industry players are developing new advanced technologies to provide better compliance and integration with IT devices, which is contributing to the market growth.
The outbreak of COVID-19 in the year 2020 has positively impacted the artificial pancreas device systems market, growth owing to the need for diabetes management in COVID-19 patients. Moreover, COVID-19 recovered diabetes patients have developed resistance to insulin, and the traditional injections fail to provide proper management. Artificial pancreas device systems (APDS) can replace the need for frequent sugar level checks and control blood glucose levels. These factors are anticipated to create huge growth opportunities for market players during the forecast period.
Moreover, regulatory bodies such as FDA are continuously approving new and innovative products, thus increasing the reach of the companies in various markets. For instance, in June 2017, Medtronic launched its latest artificial pancreas system in the U.S. market. This device is capable of automatically delivering insulin to patients when they need it. Similarly, in May 2019, Beta Bionics, Inc. & Zealand Pharma initiated an in-home trial of the iLet Bionic Pancreas system, a dual-hormone pump system intended to automatically deliver dasiglucagon and insulin.
Artificial Pancreas Device Systems Market Highlights
Artificial Pancreas Device Systems Market Growth & Trends
The global artificial pancreas device systems market size is anticipated to reach USD 980.95 million by 2030, expanding at a CAGR of 18.94% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increasing geriatric population, growing incidence of diabetes, and the rising prevalence of obesity are the major factors driving the market growth. In addition, industry players are developing new advanced technologies to provide better compliance and integration with IT devices, which is contributing to the market growth.
The outbreak of COVID-19 in the year 2020 has positively impacted the artificial pancreas device systems market, growth owing to the need for diabetes management in COVID-19 patients. Moreover, COVID-19 recovered diabetes patients have developed resistance to insulin, and the traditional injections fail to provide proper management. Artificial pancreas device systems (APDS) can replace the need for frequent sugar level checks and control blood glucose levels. These factors are anticipated to create huge growth opportunities for market players during the forecast period.
Moreover, regulatory bodies such as FDA are continuously approving new and innovative products, thus increasing the reach of the companies in various markets. For instance, in June 2017, Medtronic launched its latest artificial pancreas system in the U.S. market. This device is capable of automatically delivering insulin to patients when they need it. Similarly, in May 2019, Beta Bionics, Inc. & Zealand Pharma initiated an in-home trial of the iLet Bionic Pancreas system, a dual-hormone pump system intended to automatically deliver dasiglucagon and insulin.
Artificial Pancreas Device Systems Market Highlights
- Based on device type, the threshold suspended device system accounted for the largest market share of 74.72% in 2021; this device is used majorly for hypoglycemic conditions and automatically takes action when the patient is unable to respond
- On the contrary, the CTT segment is presumed to witness exponential growth throughout the forecast period, as it is a fully automated system that minimizes patient intervention
- North America artificial pancreas device systems market dominated with around 46.08% market share in 2021, owing to the high patient awareness levels coupled with high prevalence of obesity, as well as presence of major players in the region
- Asia Pacific is expected to grow at a rapid pace over the forecast owing, to the presence of untapped opportunities, increasing healthcare funding, and government initiatives to spread awareness about diabetes
CHAPTER 1. METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Device Type
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing Prevalence Of Diabetes
3.5.1.2 Intensive R&D Efforts By Industry Players
3.5.1.3 Rising Demand For Automated Systems For Glycemic Control
3.5.1.4 Increasing Obese Population & Sedentary Lifestyle
3.5.2 Market Restraints Analysis
3.5.2.1 High Cost Of Device Systems And Safety Concern
3.5.2.2 Stringent Regulatory Framework Stalling The Market
3.5.3 Market Opportunities Analysis
3.5.3.1 Increasing Awareness About Diabetes Preventive Care
3.6 Artificial Pancreas Device Systems: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.2 Swot Analysis, By Pest
3.7 Impact of COVID-19 on Market & Post Pandemic Insights
CHAPTER 4. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET: SEGMENT ANALYSIS, BY DEVICE TYPE, 2017 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Device Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Artificial Pancreas Device Systems Market, By Device Type, 2017 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
4.5.1 Threshold Suspend Device Systems
4.5.1.1 Threshold Suspend Device Systems Market, 2017 - 2030 (USD Million)
4.5.2 Control-To-Range (Ctr) Systems
4.5.2.1 Control-To-Range (Ctr) Systems Market, 2017 - 2030 (USD Million)
4.5.3 Control-To-Target (Ctt) Systems
4.5.3.1 Control-To-Target (Ctt) Systems Market, 2017 - 2030 (USD Million)
CHAPTER 5. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET: REGIONAL MARKET ANALYSIS, BY DEVICE TYPE, AND BY PRODUCT TYPE, 2017 - 2030 (USD MILLION)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2021 & 2030
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot
5.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
5.6 North America
5.5.1 North America Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.2 U.S.
5.5.2.1 U.S. Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.3 Canada
5.5.3.1 Canada Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.7 Europe
5.5.1 Europe Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.2 U.K.
5.5.2.1 U.K. Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.3 Germany
5.5.3.1 Germany Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.4 France
5.5.4.1 France Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.5 Italy
5.5.5.1 Italy Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.6 Spain
5.5.5.1 Spain Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8 Asia Pacific
5.8.1 Asia Pacific Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.2 Japan
5.8.2.1 Japan Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.3 China
5.8.3.1 China Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.4 India
5.8.4.1 India Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.5 Australia
5.8.5.1 Australia Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.6 South Korea
5.8.5.1 South Korea artificial pancreas device systems market, 2017 - 2030 (USD Million)
5.9 Latin America
5.9.1 Latin America Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.9.2 Brazil
5.9.2.1 Brazil artificial pancreas device systems market, 2017 - 2030 (USD Million)
5.9.3 Mexico
5.9.3.1 Mexico Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.9.4 Argentina
5.9.4.1 Argentina Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.9.5 Colombia
5.9.5.1 Colombia artificial pancreas device systems market, 2017 - 2030 (USD Million)
5.10 MEA
5.10.1 MEA Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.10.2 South Africa
5.10.2.1 South Africa Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.10.3 Saudi Arabia
5.10.3.1 Saudi Arabia Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.10.4 UAE
5.10.4.1 UAE artificial pancreas device systems market, 2017 - 2030 (USD Million)
CHAPTER 6. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET - COMPETITIVE ANALYSIS
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Company Categorization
6.2.1 Innovators
6.2.2 Market Leaders
6.3 Vendor Landscape
6.3.1 Key Company Market Share Analysis, 2021
6.3.2 Major Deals And Strategic AllianceS
6.3.2.1 New Product Launch
6.3.2.2 Expansion
6.3.2.3 Acquistion
6.3.3 Market Entry Strategies
6.4 Company Profiles
6.4.1 Medtronic
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 Strategic initiatives
6.4.2 Bigfoot Biomedical
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.3 Johnson & Johnson Services Inc.
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.4 Tandem Diabetes Care, Inc.
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.4.4 Strategic initiatives
6.4.5 Pancreum, Inc.
6.4.5.1 Company overview
6.4.5.2 Financial performance
6.4.5.3 Product benchmarking
6.4.5.4 Strategic initiatives
6.4.6 TypeZero Technologies, LLC
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.6.4 Strategic initiatives
6.4.7 Beta Bionics
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.6.4 Strategic initiatives
1.1 Market Segmentation and Scope
1.1.1 Device Type
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database:
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.2 Volume Price Analysis (Model 2)
1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
1.10.4 Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
CHAPTER 3. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List of Key End Users
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Increasing Prevalence Of Diabetes
3.5.1.2 Intensive R&D Efforts By Industry Players
3.5.1.3 Rising Demand For Automated Systems For Glycemic Control
3.5.1.4 Increasing Obese Population & Sedentary Lifestyle
3.5.2 Market Restraints Analysis
3.5.2.1 High Cost Of Device Systems And Safety Concern
3.5.2.2 Stringent Regulatory Framework Stalling The Market
3.5.3 Market Opportunities Analysis
3.5.3.1 Increasing Awareness About Diabetes Preventive Care
3.6 Artificial Pancreas Device Systems: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.2 Swot Analysis, By Pest
3.7 Impact of COVID-19 on Market & Post Pandemic Insights
CHAPTER 4. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET: SEGMENT ANALYSIS, BY DEVICE TYPE, 2017 - 2030 (USD MILLION)
4.1 Definition and Scope
4.2 Device Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Artificial Pancreas Device Systems Market, By Device Type, 2017 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2017 to 2030
4.5.1 Threshold Suspend Device Systems
4.5.1.1 Threshold Suspend Device Systems Market, 2017 - 2030 (USD Million)
4.5.2 Control-To-Range (Ctr) Systems
4.5.2.1 Control-To-Range (Ctr) Systems Market, 2017 - 2030 (USD Million)
4.5.3 Control-To-Target (Ctt) Systems
4.5.3.1 Control-To-Target (Ctt) Systems Market, 2017 - 2030 (USD Million)
CHAPTER 5. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET: REGIONAL MARKET ANALYSIS, BY DEVICE TYPE, AND BY PRODUCT TYPE, 2017 - 2030 (USD MILLION)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2021 & 2030
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot
5.5 Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2030
5.6 North America
5.5.1 North America Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.2 U.S.
5.5.2.1 U.S. Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.3 Canada
5.5.3.1 Canada Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.7 Europe
5.5.1 Europe Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.2 U.K.
5.5.2.1 U.K. Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.3 Germany
5.5.3.1 Germany Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.4 France
5.5.4.1 France Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.5 Italy
5.5.5.1 Italy Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.5.6 Spain
5.5.5.1 Spain Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8 Asia Pacific
5.8.1 Asia Pacific Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.2 Japan
5.8.2.1 Japan Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.3 China
5.8.3.1 China Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.4 India
5.8.4.1 India Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.5 Australia
5.8.5.1 Australia Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.8.6 South Korea
5.8.5.1 South Korea artificial pancreas device systems market, 2017 - 2030 (USD Million)
5.9 Latin America
5.9.1 Latin America Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.9.2 Brazil
5.9.2.1 Brazil artificial pancreas device systems market, 2017 - 2030 (USD Million)
5.9.3 Mexico
5.9.3.1 Mexico Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.9.4 Argentina
5.9.4.1 Argentina Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.9.5 Colombia
5.9.5.1 Colombia artificial pancreas device systems market, 2017 - 2030 (USD Million)
5.10 MEA
5.10.1 MEA Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.10.2 South Africa
5.10.2.1 South Africa Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.10.3 Saudi Arabia
5.10.3.1 Saudi Arabia Artificial Pancreas Device Systems Market, 2017 - 2030 (USD Million)
5.10.4 UAE
5.10.4.1 UAE artificial pancreas device systems market, 2017 - 2030 (USD Million)
CHAPTER 6. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET - COMPETITIVE ANALYSIS
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Company Categorization
6.2.1 Innovators
6.2.2 Market Leaders
6.3 Vendor Landscape
6.3.1 Key Company Market Share Analysis, 2021
6.3.2 Major Deals And Strategic AllianceS
6.3.2.1 New Product Launch
6.3.2.2 Expansion
6.3.2.3 Acquistion
6.3.3 Market Entry Strategies
6.4 Company Profiles
6.4.1 Medtronic
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 Strategic initiatives
6.4.2 Bigfoot Biomedical
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.3 Johnson & Johnson Services Inc.
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.4 Tandem Diabetes Care, Inc.
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.4.4 Strategic initiatives
6.4.5 Pancreum, Inc.
6.4.5.1 Company overview
6.4.5.2 Financial performance
6.4.5.3 Product benchmarking
6.4.5.4 Strategic initiatives
6.4.6 TypeZero Technologies, LLC
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.6.4 Strategic initiatives
6.4.7 Beta Bionics
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.6.4 Strategic initiatives
LIST OF TABLES
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 4. North America artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 5. U.S. artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 6. Canada artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 7. Europe artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 8. Europe artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 9. U.K. artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 10. Germany artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 11. France artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 12. Italy artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 13. Spain artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 14. Asia Pacific artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 15. Asia Pacific artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 16. China artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 17. Japan artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 18. India artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 19. Australia artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 20. South Korea artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 21. Latin America artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 22. Latin America artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 23. Brazil artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 24. Mexico artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 25. Argentina artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 26. Colombia artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 27. Middle East & Africa artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 28. Middle East & Africa artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 29. South Africa artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 30. Saudi Arabia artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 31. UAE artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. North America artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 4. North America artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 5. U.S. artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 6. Canada artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 7. Europe artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 8. Europe artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 9. U.K. artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 10. Germany artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 11. France artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 12. Italy artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 13. Spain artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 14. Asia Pacific artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 15. Asia Pacific artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 16. China artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 17. Japan artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 18. India artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 19. Australia artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 20. South Korea artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 21. Latin America artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 22. Latin America artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 23. Brazil artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 24. Mexico artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 25. Argentina artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 26. Colombia artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 27. Middle East & Africa artificial pancreas device systems market, by country, 2017 - 2030 (USD Million)
Table 28. Middle East & Africa artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 29. South Africa artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 30. Saudi Arabia artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
Table 31. UAE artificial pancreas device systems market, by device type, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig 1. Artificial pancreas device systems market segmentation
Fig 2. Market research process
Fig 3. Information procurement
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value-chain-based sizing & forecasting
Fig 7. QFD modeling for market share assessment
Fig 8. Market formulation & validation
Fig 9. Market outlook (2021)
Fig 10. Segment outlook
Fig 11. Strategy framework
Fig 12. Penetration & growth prospect mapping
Fig 13. Consumer behavior analysis
Fig 14. Market driver relevance analysis (Current & future impact)
Fig 15. Market restraint relevance analysis (Current & future impact)
Fig 16. Porter’s five forces analysis
Fig 17. SWOT analysis, by factor (political & legal, economic and technological)
Fig 18. Artificial pancreas device systems market: Device type movement analysis
Fig 19. Segment dashboard
Fig 20. Artificial pancreas device systems market device type outlook: Key takeaways
Fig 21. Threshold suspend device systems market, 2017 - 2030 (USD Million)
Fig 22. Control-to-Range (CTR) systems market, 2017 - 2030 (USD Million)
Fig 23. Control-to-Target (CTT) systems market, 2017 - 2030 (USD Million)
Fig 24. Regional outlook, 2021 & 2030
Fig 25. Regional market dashboard
Fig 26. Regional market place: Key takeaways
Fig 27. North America artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 28. U.S. artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 29. Canada artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 30. Europe artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 31. U.K. artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 32. Germany artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 33. France artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 34. Italy artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 35. Spain artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 36. Asia Pacific artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 37. Japan artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 38. China artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 39. South Korea artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 40. Australia artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 41. India artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 42. Latin America artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 43. Brazil artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 44. Mexico artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 45. Argentina artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 46. Colombia artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 47. MEA artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 48. South Africa artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 49. Saudi Arabia artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 50. UAE artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 51. Company market share analysis, 2021
Fig 52. Market differentiators
Fig 53. Regional network map
Fig 1. Artificial pancreas device systems market segmentation
Fig 2. Market research process
Fig 3. Information procurement
Fig 4. Primary research pattern
Fig 5. Market research approaches
Fig 6. Value-chain-based sizing & forecasting
Fig 7. QFD modeling for market share assessment
Fig 8. Market formulation & validation
Fig 9. Market outlook (2021)
Fig 10. Segment outlook
Fig 11. Strategy framework
Fig 12. Penetration & growth prospect mapping
Fig 13. Consumer behavior analysis
Fig 14. Market driver relevance analysis (Current & future impact)
Fig 15. Market restraint relevance analysis (Current & future impact)
Fig 16. Porter’s five forces analysis
Fig 17. SWOT analysis, by factor (political & legal, economic and technological)
Fig 18. Artificial pancreas device systems market: Device type movement analysis
Fig 19. Segment dashboard
Fig 20. Artificial pancreas device systems market device type outlook: Key takeaways
Fig 21. Threshold suspend device systems market, 2017 - 2030 (USD Million)
Fig 22. Control-to-Range (CTR) systems market, 2017 - 2030 (USD Million)
Fig 23. Control-to-Target (CTT) systems market, 2017 - 2030 (USD Million)
Fig 24. Regional outlook, 2021 & 2030
Fig 25. Regional market dashboard
Fig 26. Regional market place: Key takeaways
Fig 27. North America artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 28. U.S. artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 29. Canada artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 30. Europe artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 31. U.K. artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 32. Germany artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 33. France artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 34. Italy artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 35. Spain artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 36. Asia Pacific artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 37. Japan artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 38. China artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 39. South Korea artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 40. Australia artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 41. India artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 42. Latin America artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 43. Brazil artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 44. Mexico artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 45. Argentina artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 46. Colombia artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 47. MEA artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 48. South Africa artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 49. Saudi Arabia artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 50. UAE artificial pancreas device systems market, 2017 - 2030 (USD Million)
Fig 51. Company market share analysis, 2021
Fig 52. Market differentiators
Fig 53. Regional network map
